Correlation Between Tarsus Pharmaceuticals and Pear Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Pear Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Pear Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Pear Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Pear Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Pear Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Pear Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Pear Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tarsus and Pear is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Pear Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pear Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Pear Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pear Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Pear Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Pear Therapeutics
If you would invest 2,731 in Tarsus Pharmaceuticals on December 4, 2024 and sell it today you would earn a total of 1,541 from holding Tarsus Pharmaceuticals or generate 56.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Pear Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Pear Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Tarsus Pharmaceuticals and Pear Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Pear Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Pear Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Pear Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pear Therapeutics will offset losses from the drop in Pear Therapeutics' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Pear Therapeutics vs. Cheche Group Class | Pear Therapeutics vs. CDW Corp | Pear Therapeutics vs. Datadog | Pear Therapeutics vs. Analog Devices |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |